Serum Institute of India (SII): Racing to Save Lives During a Pandemic

Case Solution

Rohit Deshpande, Anjali Raina, Rachna Chawla
Harvard Business School ()

The CEO of the Serum Institute of India (SII), a $ 12.8 billion Indian family business, faces a risky choice between principles and benefits. SII is the world’s largest vaccine manufacturer and Adar Poonawalla, CEO and son of the founder, must decide how to mitigate his responsibilities to meet the global need for an affordable, effective, and safe COVID19 vaccine and remain profitable.

We don‘t have the case solution, but we pay up to $50 for yours!

  • Set a reminder to receive an email after your university‘s case study deadline.
  • Upload your case study solution. We will review it for quality.
  • Get your money via PayPal or to your bank account.